Newsletter

A short monthly email on women's hormonal health — what's new in menopause/HRT, GLP-1 for women, PCOS, and the providers we cover. No spam, no health questionnaires, no behavioral tracking.

What you'll get (preview)

Monthly digest #3 · May 2026

What patients are reading

📰

Compounded GLP-1 enforcement update

FDA shortage list ending narrows compounder window. Implications for cost + insurance pivot.

🧰

New tool: Treatment success calculator

Pick symptom + duration. See probability ranges from clinical trials.

📊

Outcomes leaderboard update

6 brand outcome stats updated this month. 2 new entries.

✉

Coming next month

STRAW+10 perimenopause staging framework deep-dive.

What you'll get

New brand reviews and quarterly re-verifications
Treatment news (FDA approvals, brand pivots, compounding changes)
STRAW+10 stage explainers and symptom deep-dives
Editorial picks for "best of" categories

What you won't get

Health questionnaires or symptom intake forms
Brand-paid sponsored content disguised as editorial
Affiliate-driven recommendations (we never reorder based on commission)
More than one email per month — usually less

Reviewed by clinicians

Every newsletter is read by one of our medical advisors before sending. The same standard we apply to site content.

Privacy

We store your email with our newsletter provider (Beehiiv). We don't pass it to brands, never sell it, and don't use it for cross-site tracking. See our privacy policy.